SCHEMBL23366111

SCHEMBL23366111

Fc1ccc(NCS)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.46
RPS6KA2 Q15349 1/20 0.41
MAPT P10636 2/20 0.39
KCNH3 Q9ULD8 3/20 0.38
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
PLEC Q15149 1/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 1/20 0.37
KDM4E B2RXH2 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11516786 0.82 IDO1 (0.44) IDO1RPS6KA2MAPTKCNH3ALDH1A1
SCHEMBL2064760 0.80 MAPT (0.57) RPS6KA2MAPTKCNH3ALDH1A1MEN1
SCHEMBL16526575 0.74 RPS6KA2 (0.41) IDO1RPS6KA2MAPTKCNH3ALDH1A1
SCHEMBL416817 0.74 APP (0.47) RPS6KA2MAPTKCNH3ALDH1A1MEN1
SCHEMBL2096635 0.74 RPS6KA2 (0.41) IDO1RPS6KA2MAPTKCNH3ALDH1A1
SCHEMBL378330 0.74 MAPT (0.48) RPS6KA2MAPTKCNH3ALDH1A1MEN1
SCHEMBL12652043 0.74 IDO1 (0.46) IDO1MAPTALDH1A1MEN1KMT2A
SCHEMBL14145331 0.74 MAOA (0.43) IDO1RPS6KA2MAPTKCNH3ALDH1A1
SCHEMBL12652046 0.73 KIF11 (0.47) MAPTMEN1KMT2ALMNACA1
SCHEMBL820286 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11008290-B2 Halogenated quinoline derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2021-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11008290-B2 Halogenated quinoline derivatives as antimicrobial agents NDUFS5, NDUFS7, NDUFS3 IDO1 29/4885RPS6KA2 3751/4885MAPT 4764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.